{
  "ptid_time": "037_S_4302_2011-10-26",
  "img_path": "/data/qiuhui/data/adni/images/037_S_4302/2011-10-26/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 67,835 mm³, 76.1% above the reference mean. With a Z-score of 1.82 (96.6th percentile), this represents moderate enlargement; hippocampal volume measures 7,038 mm³, 6.9% below the reference mean. With a Z-score of -0.67 (25.1th percentile), this represents normal volume ; whole brain volume measures 1,030,420 mm³, 4.5% below the reference mean. With a Z-score of -0.59 (27.8th percentile), this represents normal volume ; entorhinal cortex volume measures 3,919 mm³, 4.4% below the reference mean. With a Z-score of -0.30 (38.2th percentile), this represents normal volume ; fusiform gyrus volume measures 19,940 mm³, 5.8% above the reference mean. With a Z-score of 0.50 (69.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,064 mm³, 10.7% below the reference mean. With a Z-score of -0.96 (16.9th percentile), this represents normal volume . ",
  "text_data": "Age is 76.1 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 25.0. MoCA: 20.0. Logical Memory: 1.0. Laboratory findings: Serum Glucose: 158.00 (profound elevated); GGT: 45.00 (significant elevated); Phosphorus: 2.50 (significant reduced). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.21 SUVR (mild elevated); Amyloid beta: 948.30 pg/mL (normal ); Total tau: 321.10 pg/mL (mild elevated); Phosphorylated tau: 31.98 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows moderate ventricular enlargement (suggesting atrophy) but otherwise normal hippocampal, whole brain, and regional cortical volumes. Cognitive testing (MMSE 25, MoCA 20) indicates mild impairment, while biomarkers (normal Aβ but mildly elevated tau and AV45) suggest possible early neurodegenerative changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores and ventricular enlargement support MCI, but biomarker profile is atypical for typical AD progression, and volumes are largely normal.)",
  "timestamp": "2025-07-26T06:43:44.656047"
}